AstraZeneca plc Lowered to “Underweight” at Barclays
26th January 2015
Barclays lowered shares of AstraZeneca plc (LON:AZN) to an underweight rating in a research report released on Friday morning.
Barclays has also modified their ratings on a number of other stocks in the few days. The firm lowered its price target on shares of Goldcorp Inc. from $30.00 to $26.00. They have an overweight rating on that stock. Also, Barclays lowered its price target on shares of Eldorado Gold Corp from $8.00 to $7.00. They have an equal weight rating on that stock. Finally, Barclays lowered its price target on shares of Agnico Eagle Mines Ltd from $35.00 to $32.00. They have an equal weight rating on that stock.
Read more at source article www.tickerreport.com